Modified virus targets Hard-to-Treat cancers in groundbreaking trial
Disease control
Recruiting now
This first-in-human study is testing an experimental cancer treatment called IDOV-Immune, which uses a modified virus designed to infect and destroy cancer cells while boosting the immune system. The trial aims to find the safest dose and check for early signs that the treatment …
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC